title: Re: Triantafillidis et al.--Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment.
authors.forename: D S
authors.initials: DS
authors.lastname: Fefferman
authors.forename: M
authors.initials: M
authors.lastname: Alsahli
authors.forename: P J
authors.initials: PJ
authors.lastname: Lodhavia
authors.forename: S A
authors.initials: SA
authors.lastname: Shah
authors.forename: R J
authors.initials: RJ
authors.lastname: Farrell
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D010195:Pancreatitis / Q000150:complications* / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab